AIM
CNCE
Alambic Investment Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-19,934
| Closed | -$196K | – | 54 |
|
|
2020
Q3 | $196K | Buy |
19,934
+2,034
| +11% | +$20K | 2.15% | 15 |
|
|
2020
Q2 | $178K | Hold |
17,900
| – | – | 0.45% | 106 |
|
|
2020
Q1 | $158K | Sell |
17,900
-3,416
| -16% | -$30.2K | 0.38% | 102 |
|
|
2019
Q4 | $197K | Buy |
+21,316
| New | +$197K | 0.16% | 208 |
|